Prostate cancer: To scan or not to scan for lymph node involvement?

Scandinavian Journal of Urology and Nephrology

Volumn 41, Issue 6, 2007, Pages 501-506

  Heebøll, Sara ^a   Solvig, Jan ^a   Borre, Michael ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

CT; Lymph nodes; Metastases; MRI; Prostate cancer; Ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HIGH RISK BEHAVIOR; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; ULTRASOUND;

AGED; DISEASE PROGRESSION; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 36749102613     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590701486010     Document Type: Article

References (19)

1. Gervasi LA, Mata J, Easly JD, Wilbanks JH, Seale-Hawkins C, Carlton CE, et al. Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 1989;142:332-6.
2. Daneshmand S, Quek ML, Stein JP, Lieskovsky G, Cai J, Pinski J, et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 2004;172:2252-5.
3. Tempany CMC, McNiel BJ. Advances in biomedical imaging. JAMA 2001;285:562-7.
4. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001;58:843-8.
5. Borley NC, Fabrin K, Poulsen J, Sriprasad S, Mondaini N, Thompson PM, et al. Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in "high-risk" prostate cancer compared to MRI or CT. Scand J Urol Nephrol 2003;37:382-6.
6. Huncharek M, Muscat J. Serum prostate-specific antigen as a predictor of staging abdominal/pelvic computed tomography in newly diagnosed prostate cancer. Abdom Imaging 1996;21:364-7.
7. Abuzallouf S, Dayes I, Lukka H. Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol 2004;171:2122-7.
8. Magnusson A, Fritjofsson Å, Norlen BJ, Wicklund H. The value of computed tomography and ultrasound in assessment of pelvic lymph node metastases in patients with clinically locally confined carcinoma of the prostate. Scand J Urol Nephrol 1988;22:7-10.
9. Wolf JS, Cher M, Dall'era M, Presti JC, Hricak H, Carroll PR. Prostate cancer: the use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol 1995;153:993-9.
10. Bader P, Burkhart FC, Markwalder R, Studer UE. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 2002;168:514-8.
11. Burkhard FC, Studer UE. The role of lymphadenectomy in prostate cancer. Urol Oncol 2004;22:198-202.
12. Burkhart FC, Schumacher M, Thalmann GN, Studer UE. Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/mL undergoing radical prostatectomy for prostate cancer? BJU Int 2005;95:275-8.
13. Allaf ME, Palapattu GS, Trock BJ, Carter HB, Walsh PC. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 2004;172:1840-4.
14. Heidenreich A, Varga Z, von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 2002;167:1681-6.
15. Tiguert R, Gheiler EL, Tefilli MV, Oskanian P, Banerjee M, Grignon DJ, et al. Lymph node size does not correlate with the presence of prostate cancer metastasis. Urology 1999;53:367-71.
16. Jeschke S, Thigarajan N, Leeb K, Ziegerhofer J, Sega W, Janetschek G. Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 2005;173:1943-6.
17. Wawroschek F, Hamm M, Weckermann D, Vogt H, Harzmann R. Lymph node staging in clinically localized prostate cancer. Urol Int 2003;71:129-35.
18. Schmid DT, John H, Zweifel R, Cservenyak T, Westera G, Goerres GW, et al. Fluorocholine PET/CT in patients with prostate cancer: initial experience. Radiology 2005;235:623-8.
19. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, et al. Non-invasive detection of clinically occult lymph node metastases in prostate cancer. N Engl J Med 2003;348:2491-9.